Evidence map›Paper›PMID 32975621›Full record

SynthesisZeitschrift fur Rheumatologie2020

Efficacy of local injection therapy for heel pain in rheumatic inflammatory diseases: A systematic review.

K B Abdelghani, L Rouached, A Fazaa, S Miladi, K Ouenniche, L Souabni, S Kassab, S Chekili, A Laatar

Abstract readSystematic Review
PubMed Publisher
In one paragraph

Synthesis in Zeitschrift fur Rheumatologie, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.9field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 9 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

K B AbdelghaniRheumatology Department, Mongi Slim Hospital, La Marsa, Tunisia. leila_rouached@hotmail.com.
L RouachedRheumatology Department, Mongi Slim Hospital, La Marsa, Tunisia.
A FazaaRheumatology Department, Mongi Slim Hospital, La Marsa, Tunisia.
S MiladiRheumatology Department, Mongi Slim Hospital, La Marsa, Tunisia.
K OuennicheRheumatology Department, Mongi Slim Hospital, La Marsa, Tunisia.
L SouabniRheumatology Department, Mongi Slim Hospital, La Marsa, Tunisia.
S KassabRheumatology Department, Mongi Slim Hospital, La Marsa, Tunisia.
S ChekiliRheumatology Department, Mongi Slim Hospital, La Marsa, Tunisia.
A LaatarRheumatology Department, Mongi Slim Hospital, La Marsa, Tunisia.
Tunis El Manar University · TNHôpital Mongi Slim · TN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Heel pain or achillodynia is one of the most common manifestations in patients with rheumatic inflammatory diseases (RID) and particularly spondyloarthritis (SpA). It can be associated with inflammation at the bone insertion of tendon, ligament, bursa or fascia. However, treatment is still a challenge for rheumatologists. Several findings highlighted the proven benefit of nonsteroidal anti-inflammatory drugs (NSAIDs), disease-modifying antirheumatic drugs (DMARDs), and recently, tumor necrosis factor (TNF)-α inhibitors. However, only limited data about the efficacy of local therapy such as glucocorticoid and anti-TNF injections are available. The aim of this systematic review was to assess the efficacy and safety of local therapies in heel pain and to make recommendations for further studies. Five studies discussing the effectiveness of local treatments of heel pain in RID were included. All studies recognized that the ultrasonography (US)-guided local corticosteroid or etanercept injections were effective and safe modalities for the treatment of inflammatory heel enthesitis, tendinitis, and retrocalcaneal bursitis (RCB) in patients with RID. Pain relief at the local site was associated with a reversion of the acute inflammatory changes in the heel. Furthermore, US-guided injection in RCB with a lateral approach was beneficial in terms of preventing side effects.

Indexed as

HeelPain ManagementRheumatic DiseasesTendinopathyAntirheumatic AgentsBursitisFasciitisHumansInjectionsPainTumor Necrosis Factor-alphaAntirheumatic AgentsTumor Necrosis Factor-alphaAchilles tendonEnthesopathyRheumatoid arthritisSpondyloarthropathiesUltrasound

Identifiers

PMID32975621
OpenAlexW3088593468

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.